Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jun 23;22(13):6711.
doi: 10.3390/ijms22136711.

The Role of ABC Transporters in Lipid Metabolism and the Comorbid Course of Chronic Obstructive Pulmonary Disease and Atherosclerosis

Stanislav Kotlyarov  1 , Anna Kotlyarova  2
Affiliations
Review

The Role of ABC Transporters in Lipid Metabolism and the Comorbid Course of Chronic Obstructive Pulmonary Disease and Atherosclerosis

Stanislav Kotlyarov et al. Int J Mol Sci. .

Abstract

Chronic obstructive pulmonary disease (COPD) ranks among the leading causes of morbidity and mortality worldwide. COPD rarely occurs in isolation and is often combined with various diseases. It is considered that systemic inflammation underlies the comorbid course of COPD. The data obtained in recent years have shown the importance of violations of the cross-links of lipid metabolism and the immune response, which are links in the pathogenesis of both COPD and atherosclerosis. The role of lipid metabolism disorders in the pathogenesis of the comorbid course of COPD and atherosclerosis and the participation of ATP-binding cassette (ABC) transporters in these processes is discussed in this article. It is known that about 20 representatives of a large family of ABC transporters provide lipid homeostasis of cells by moving lipids inside the cell and in its plasma membrane, as well as removing lipids from the cell. It was shown that some representatives of the ABC-transporter family are involved in various links of the pathogenesis of COPD and atherosclerosis, which can determine their comorbid course.

Keywords: ABC transporters; COPD; atherosclerosis; chronic obstructive pulmonary disease; inflammation; lipid metabolism.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Schematic image of the involvement of ABC transporters in the pathogenesis of COPD and atherosclerosis.
Figure 2
Figure 2
Biological processes and molecular functions of ABC transporters in the pathogenesis of COPD and atherosclerosis.
See this image and copyright information in PMC

References

    1. May S.M., Li J.T. Burden of chronic obstructive pulmonary disease: Healthcare costs and beyond. Allergy Asthma Proc. 2015;36:4–10. doi: 10.2500/aap.2015.36.3812. - DOI - PMC - PubMed
    1. Quaderi S.A., Hurst J.R. The unmet global burden of COPD. Glob. Health Epidemiol. Genom. 2018;3:e4. doi: 10.1017/gheg.2018.1. - DOI - PMC - PubMed
    1. Soriano J.B., Kendrick P.J., Paulson K.R., Gupta V., Abrams E.M., Adedoyin R.A., Adhikari T.B., Advani S.M., Agrawal A., Ahmadian E., et al. Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir. Med. 2020;8:585–596. doi: 10.1016/S2213-2600(20)30105-3. - DOI - PMC - PubMed
    1. Barnes P.J. COPD 2020: New directions needed. Am. J. Physiol. Lung Cell Mol. Physiol. 2020;319:L884–L886. doi: 10.1152/ajplung.00473.2020. - DOI - PubMed
    1. Castaldi P.J., Benet M., Petersen H., Rafaels N., Finigan J., Paoletti M., Marike Boezen H., Vonk J.M., Bowler R., Pistolesi M., et al. Do COPD subtypes really exist? COPD heterogeneity and clustering in 10 independent cohorts. Thorax. 2017;72:998–1006. doi: 10.1136/thoraxjnl-2016-209846. - DOI - PMC - PubMed

MeSH terms

Substances